The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

• Status: Unknown status
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the better preoperative anti-tuberculosis treatment period of patients with spinal tuberculosis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Chest Hospital
• Collaborator: Beijing Municipal Science & Technology Commission
• Treatments: Antitubercular Agents; Ethambutol; Isoniazid; Pyrazinamide; Rifampin

Criteria

Inclusion Criteria:

• Patients are diagnosed as spinal tuberculosis clinically,and they do not receive antituberculosis therapy or with 2 weeks.

• The age is between 15 years old and 75 years old.

• Patients have good compliance,and have clear surgical indications.4.Willing to join the research

Exclusion Criteria:

• Patients have surgical contraindications.

• Patients have bad habits:taking drug,drinking.3.Patients have mental disease.

• Patients have bad compliance.

• Patients have hematogenous disseminated pulmonary tuberculosis, serious central nervous system tuberculosis,and serious extrapulmonary tuberculosis.

• Patients with drug resistance for Antituberculosis drugs,and patient have to change the treat plan,and patients have immunodeficiency diseases.

• Patients are not diagnosed as spinal tuberculosis clearly.

• Not willing to join the research